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Mechanism for Aar2p function as a U5
snRNP assembly factor
Gert Weber,1,3 Vanessa F. Crista˜o,2,3 Flavia de L. Alves,2 Karine F. Santos,1 Nicole Holton,1
Juri Rappsilber,2 Jean D. Beggs,2,4 and Markus C. Wahl1
1Fachbereich Biologie/Chemie/Pharmazie, Abteilung Strukturbiochemie, Freie Universita¨t Berlin, D-14195 Berlin, Germany;
2Wellcome Trust Centre for Cell Biology, University of Edinburgh, Edinburgh EH9 3JR, United Kingdom
Little is known about how particle-specific proteins are assembled on spliceosomal small nuclear ribonucleo-
proteins (snRNPs). Brr2p is a U5 snRNP-specific RNA helicase required for spliceosome catalytic activation and
disassembly. In yeast, the Aar2 protein is part of a cytoplasmic precursor U5 snRNP that lacks Brr2p and is
replaced by Brr2p in the nucleus. Here we show that Aar2p and Brr2p bind to different domains in the C-terminal
region of Prp8p; Aar2p interacts with the RNaseH domain, whereas Brr2p interacts with the Jab1/MPN domain.
These domains are connected by a long, flexible linker, but the Aar2p–RNaseH complex sequesters the Jab1/MPN
domain, thereby preventing binding by Brr2p. Aar2p is phosphorylated in vivo, and a phospho-mimetic S253E
mutation in Aar2p leads to disruption of the Aar2p–Prp8p complex in favor of the Brr2p–Prp8p complex. We
propose a model in which Aar2p acts as a phosphorylation-controlled U5 snRNP assembly factor that regulates the
incorporation of the particle-specific Brr2p. The purpose of this regulation may be to safeguard against nonspecific
RNA binding to Prp8p and/or premature activation of Brr2p activity.
[Keywords: pre-mRNA splicing; protein interaction; protein phosphorylation; protein structure; spliceosome; yeast]
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Small ribonucleoproteins (RNPs) are major components
of several RNA processing machineries in eukaryotic
cells, including spliceosomes, which catalyze the re-
moval of noncoding intervening sequences (introns) from
precursor messenger RNAs (pre-mRNAs) and the ligation
of the neighboring coding regions (exons) to generate
mature mRNA. Canonical small nuclear RNPs (snRNPs),
such as the U1, U2, U4, and U5 snRNPs of the major
spliceosome, contain a set of seven common Sm proteins
bound at a uridine-rich Sm site in the snRNAs, forming
the Sm core RNPs (Pomeranz Krummel et al. 2009;Weber
et al. 2010). In metazoans, Sm core RNPs are assembled
via an elaborate pathway involving nucleo–cytoplasmic
shuttling and two multiprotein machineries, the Prmt5
and the SMN complexes (for review, see Kolb et al. 2007;
Chari et al. 2009). In addition, each snRNP contains
a variable number of particle-specific proteins. The final
stages of metazoan snRNP biogenesis are thought to take
place in nuclear Cajal bodies, at least in the case of the U2
snRNP (Nesic et al. 2004). However, little is known about
how the specific proteins are assembled.
Spliceosomes assemble de novo on the substrate pre-
mRNAs by stepwise recruitment of the snRNPs and
many additional splicing factors that are not stably
associated with snRNPs (for review, see Wahl et al.
2009). During the cycle of assembly, activation, catalysis,
and disassembly, the spliceosome is repeatedly remod-
eled with the help of eight conserved RNA-dependent
ATPases/RNA helicases and one G-protein (for review,
see Staley and Guthrie 1998). Each remodeling step is
associated with changes in the macromolecular compo-
sition and in the protein–protein, protein–RNA, and
RNA–RNA interaction networks of the spliceosome
(Wahl et al. 2009). During the splicing cycle, several
snRNPs are also profoundly reorganized. For example,
the human U5 snRNP enters the spliceosome as a 20S
particle that is part of the U4/U6–U5 tri-snRNP, in which
the U4 and U6 snRNAs are extensively base-paired.
During spliceosome activation, the U4 and U6 snRNAs
are separated and all U4/U6-specific proteins are removed
to make U6 snRNA available as part of the active site(s)
(Staley and Guthrie 1998; Wahl et al. 2009). Upon
catalytic activation, several components of the multi-
protein Prp19 complex (the nineteen complex, NTC, in
yeast) become stably associated with U5 snRNP. As
a consequence, U5 snRNP is released as a 35S particle
from the post-splicing complex, from which the 20S form
has to be recycled via an unknown pathway (Makarov
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et al. 2002). Thus, snRNP assembly, restructuring, and
reassembly are intimately tied to the splicing process
itself.
Two distinct forms of U5 snRNP have been character-
ized in yeast, distinguished by the presence or absence of
the Aar2 protein (Gottschalk et al. 2001; Boon et al. 2007).
Aar2p was discovered as a factor involved in the splicing
of some pre-mRNAs in yeast (Nakazawa et al. 1991).
While Aar2p is not required for splicing per se, removal of
the protein blocked repeated rounds of splicing in vitro
(Gottschalk et al. 2001), suggesting that it could be
involved in U5 snRNP or U4/U6–U5 tri-snRNP (re)as-
sembly. More recently, it was shown that the Aar2p-U5
snRNP has a cytoplasmic phase (Boon et al. 2007). In
addition to Aar2p and the Sm proteins, it contains the U5-
specific Prp8 and Snu114 proteins, but it lacks the
essential Brr2 helicase (Gottschalk et al. 2001; Boon
et al. 2007) that is required for spliceosome activation
(Staley and Guthrie 1998) and disassembly (Small et al.
2006). In the nucleus, Aar2p is replaced by Brr2p, which,
along with the remaining U5-specific proteins, gives rise
to mature U5 snRNP (Boon et al. 2007).
Here, we investigated the structural basis of Aar2p’s
association with Prp8p and the mechanism by which it
regulates U5 snRNP biogenesis in Saccharomyces cer-
evisiae. We found that Aar2p forms a stable complex with
the RNaseH-like domain of Prp8p, and the C terminus of
Aar2p sequesters the C-terminal Jab1/MPN domain of
Prp8p, which is a major interaction site of Brr2p. Thus,
Aar2p directly competes with Brr2p for binding to Prp8p.
Aar2p is found to be phosphorylated in vivo, including
residue S253. Introduction of a phospho-mimetic muta-
tion in Aar2p at position 253 disrupts the Aar2p–Prp8p
interaction and allows Brr2p entry. Our data suggest that
Aar2p acts as a phosphorylation-controlled U5 snRNP
assembly factor that regulates the interaction of Brr2p,
possibly to avoid nonspecific RNA binding by Prp8p and/
or premature activation of Brr2p activity.
Results
Aar2p stably interacts with the RNaseH-like domain
in the C-terminal region of Prp8p
Previous work suggested that Aar2p interacts with a
C-terminal region of Prp8p (Boon et al. 2006, 2007),
although a direct contact between the proteins was not
demonstrated. We tested interaction of full-length Aar2p
fused to the LexA DNA-binding domain (in pBTM116)
with HA-tagged C-terminal Prp8p fragments fused to the
Gal4 activation domain (in pACTII). Prp8pE1 (residues
1649–2413) includes the RNaseH and Jab1/MPN do-
mains, Prp8pE3 (residues 2010–2413) includes the Jab1/
MPN domain but lacks most of the RNaseH domain, and
Prp8pE3H (residues 2010–2413) carries two point muta-
tions (Y2037H, I2051T) that increase its interaction with
Brr2p (Fig. 1A; van Nues and Beggs 2001). As the Aar2-
LexA fusion protein alone activated transcription in yeast
two-hybrid assays, we tested interactions among the
proteins using pull-down assays instead. Aar2-LexAp
coprecipitated the Prp8E1 fusion protein but not Prp8pE3
or Prp8pE3H (Fig. 1B), indicating that Aar2p binds the
C-terminal region of Prp8p and that this interaction re-
quires sequence in the E1 fragment between residues 1649
and 2010.
We next used analytical gel filtration analysis to assess
the interaction between Aar2-His6p and fragments of
Prp8p, both recombinantly produced in Escherichia coli.
Upon mixing individually purified proteins, Aar2-His6p
coeluted with Prp8p1836-2413 (covering the RNaseH and
Jab1/MPN domains; herein referred to as Prp8pCTF) at the
expected size of a 1:1 complex (Fig. 1C–E). The two
proteins could also be coproduced and copurified via
three chromatographic steps (Supplemental Fig. S1A),
confirming a stable and direct interaction of Aar2-His6p
and Prp8pCTF. Similarly, Aar2-His6p stably bound to
Prp8p1836–2092 (Prp8pRNaseH). While Aar2-His6p also
comigrated with Prp8p2112–2413 (Prp8pJab1/MPN), the elu-
tion volume was the same as for the individual proteins,
showing that Aar2-His6p does not stably interact with
Prp8pJab1/MPN (Fig. 1F–H). The latter finding was con-
firmed in a pull-down assay (Supplemental Fig. S1B).
Thus, Aar2p binds directly to the C-terminal region of
Prp8p, and the RNaseH domain of Prp8p is the primary
interaction module for Aar2p.
Crystal structure analysis of Prp8pCTF*, Aar2p,
and an Aar2p–Prp8pRNaseH complex
To reveal the molecular basis of the Aar2p–Prp8p in-
teraction, we attempted to crystallize the Aar2-His6p–
Prp8pCTF complex but failed. However, we could eluci-
date the crystal structure of Prp81836–2397 (called
Prp8pCTF*) alone, using all data collected up to 3.3 A˚
resolution in the refinement (Fig. 2A; Supplemental Table
S1; Supplemental Fig. S2A). Prp8pCTF* lacked 16 amino
acids at the C terminus compared with Prp8pCTF. In
that structure, a 60-residue linker between the domains
lacked electron density, demonstrating its intrinsic flex-
ibility (Fig. 2A). In the crystal structure, the unstructured
linker could bridge various pairs of crystallographically
equivalent domains (e.g., a closely interacting pair com-
pared with a pair of domains in an open conformation)
(Fig. 2A) and we could not unequivocally attribute a par-
ticular pair of domains to the Prp8pCTF* molecule in our
crystals. However, individually produced RNaseH and
Jab1/MPN domains ran as separate entities in gel filtra-
tion (Fig. 1C,F). In addition, protease cleavage in the
linker of Prp8pCTF dissected RNaseH and Jab1/MPN
domains that again migrated as individual proteins (Fig.
2B). These data suggest that in solution, Prp8pCTF adopts
an open conformation in which the two domains are
disconnected.
As the Aar2-His6p–Prp8p
RNaseH complex also failed to
crystallize, we suspected additional flexible elements in
Aar2-His6p and subjected the protein to limited proteol-
ysis. Subtilisin cleaved Aar2-His6p into two fragments
of;18 kDa each, comprising residues 1–159 and 168–324
(Supplemental Fig. S1C). Thus, subtilisin removed an
internal loop (residues 160–167) and the C-terminal 31
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amino acids plus the tag of the protein. Gel filtration
analysis indicated that the two fragments of subtilisin-
treated Aar2p (Aar2pSub) remained stably associated. Like
full-lengthAar2-His6p,Aar2p
Sub bound stably to Prp8pRNaseH
(Fig. 1I) but failed to interact with Prp8pJab1/MPN (data not
shown).
Aar2pSub crystallized alone and in complex with
Prp8pRNaseH. We first solved the structure of the complex
by molecular replacement using the structure coordi-
nates of isolated Prp8pRNaseH (Pena et al. 2008; PDB IDs:
3E9O and 3E9P). The Aar2pSub structure was subse-
quently solved using the coordinates of the Aar2pSub
portion of the complex structure. Both structures were
refined to low R/Rfree factors with good stereochemistry,
using all diffraction data collected to 2.1 A˚ (Aar2pSub) and
1.8 A˚ (Aar2pSub–Prp8pRNaseH complex) resolution (Sup-
plemental Table S1; Supplemental Fig. S2B,C).
Prp8pRNaseH grasps Aar2pSub between its thumb
and fingers
Aar2pSub is organized in two globular domains, connected
via a flexible loop between residues 153 and 171, part of
which was cleaved during subtilisin treatment (Figs. 3A;
Supplemental Figs. S2D, S3). The two domains interact
closely via an extensive hydrophobic interface (53%
nonpolar atoms) that buries 1504 A˚2 of combined surface
area (Supplemental Fig. S2E), explaining why they re-
mained stably associated after subtilisin treatment. The
N-terminal domain (NTD) contains a 10-stranded, mixed
b sandwich with three helices surrounding the upper rim.
Figure 1. Aar2p–Prp8p interaction. (A) A
schematic representation of the Prp8p con-
structs used in this work. For simplicity,
only the RNaseH and Jab1/MPN domains
are shown. (B) Aar2-LexAp interacts with
Prp8-HAp fragment E1, but not with E3 or
E3H. (Left panel) Yeast extracts containing
Aar2-LexAp and HA-tagged Prp8pE1,
Prp8pE3, or Prp8pE3H, or a control with no
Prp8 fusion protein () were precipitated
with anti-LexA antibodies followed by
anti-HA Western blot. (Right panel) Subse-
quent probing with anti-LexA shows that
Aar2-LexAp was immunoprecipitated simi-
larly in each case. (C–I) Gel filtration anal-
ysis of the indicated proteins or mixtures.
(Left) SDS PAGE analysis of eluted fractions
(indicated at the top). The first two lanes in
each panel show molecular mass standard
(M) and the input (I). Numbers on the left
indicate the molecular mass of standard
proteins in kilodaltons. (Right) Elution pro-
files. Elution volumes are given at the
bottom. Fractions analyzed by SDS PAGE
(shaded area) are indicated at the top.
(Aar2pSub) Subtilisin-treated Aar2p. Icons
denote proteins and complexes as defined.
Role of Aar2p in U5 snRNP assembly
GENES & DEVELOPMENT 1603
The C-terminal domain (CTD) shows an all-helical fold
with nine a helices, a p helix, and three 310 (h) helices.
Residues 319–324 were not seen in the electron density of
either Aar2pSub alone or in the complex with Prp8pRNaseH.
As previously seen in the isolated protein (Pena et al.
2008; Ritchie et al. 2008; Yang et al. 2008), the Prp8p
portion in the complex adopts a central mixed a/b fold
reminiscent of RNaseH-like enzymes, with a long b-hair-
pin insertion (residues 1859–1875) and an additional
C-terminala-helical domain (Fig. 3A). Globally, Prp8pRNaseH
resembles a mitten with the RNaseH-like core represent-
ing the palm, the b-hairpin insertion representing the
thumb, and the helical appendage corresponding to the
fingers. The fingers and thumb contact Aar2pSub through
two discontinuous interfaces (I and II) with a large gap
above the palm region in between (Fig. 3A). At interface
I, the tip of the Prp8pRNaseH fingers (formed by the C
terminus of helix H6 of Prp8pRNaseH) interacts with both
Aar2pSub domains primarily via hydrogen bonds and ionic
interactions (Fig. 3C, left). At interface II, the thumb of
Prp8pRNaseH latches onto one side of the Aar2pSub CTD,
running along a cleft between helices a10 and a13 with
polar interactions dominating the upper part and hydro-
phobic interactions prevailing in the lower part of the con-
tact (Fig. 3C, right).
Of the combined surface area, 772 A˚2 is buried upon
complex formation. An extended electronegative surface
patch on Aar2pSub at interface II and across the gap faces
a similarly extensive electropositive surface area on the
thumb and palm of Prp8pRNaseH (Fig. 3B). The association
of Aar2pSub with Prp8pRNaseH has hallmarks of a faculta-
tive interaction, since large parts of the interfaces are
hydrophilic (30% nonpolar atoms) and thus compatible
with exposure to the aqueous environment. Indeed, the
surface areas of the proteins facing each other across the
gap are blanketed with water molecules (Fig. 3D).
The structure of Aar2pSub in isolation is very similar to
the Prp8pRNaseH-bound structure (root-mean-square de-
viation ½RMSD of 0.92 A˚ for 289 Ca atoms) (Supplemen-
tal Fig. S2F, left), with significant adjustments only in
the loop between strands b5 and b6 (NTD) and in the
neighborhood of helices h3 and a11 (CTD). While the
b5–b6 loop undergoes an approximate rigid body move-
ment, the region between helices h3 and a11 is structur-
ally rearranged upon complex formation (Supplemental
Fig. S2G). Similarly, there are only limited changes in the
Prp8pRNaseH structure upon interaction with Aar2pSub,
which entail small rigid body movements of the thumb
and the tip of the fingers toward each other to grasp
Aar2pSub in between (Supplemental Fig. S2F, right).
Part of the Aar2pSub–Prp8pRNaseH interaction
resembles cargo binding by vesicular
transport adaptors
Comparison of the Aar2pSub structure to known struc-
tures in the Protein Data Bank (http://www.pdb.org)
revealed the NTD as a novel fold. Although it resembles
diverse proteins with similar b sandwiches, no other
protein has analogous interspersed helices. The CTD of
Aar2pSub is most similar to the domain of Pcf11p that
binds Ser2-phosphorylated heptad repeats of the C-termi-
nal tail of RNA polymerase II (Z-score = 7.4, RMSD 3.6 A˚
for 112 Ca atoms) and to the related families of VHS and
ENTH domains known from Golgi-ER transport adaptors
and endocytic adaptor proteins, respectively (Z-score =
7.0 to the VHS domains of human GGA1 and GGA3;
RMSD 3.7 A˚ for 111 Ca atoms; Fig. 3E). The helical stack
of the CTD also resembles armadillo repeat proteins such
as b-catenin or importin-b, posing the question of whether
Aar2p may act as a transport adaptor for pre-U5 snRNP
during nucleo–cytoplasmic shuttling. However, Prp8p has
its own nuclear localization signal (Boon et al. 2007).
VHS domain proteins bind acidic cluster–dileucine
motifs of their cargo proteins between two helices in an
extended conformation (Fig. 3F; Misra et al. 2002; Shiba
et al. 2002). This mode of cargo binding resembles the
binding of the thumb region of Prp8pRNaseH to the CTD of
Aar2pSub, although the atomic contacts differ in detail;
the Aar2pSub–Prp8pRNaseH interaction displays a different
arrangement of polar and hydrophobic interactions, and
amino acids from both strands of the Prp8pRNaseH b
hairpin bind to Aar2pSub. In contrast, Pcf11p binds Ser2-
phosphorylated RNA polymerase II heptad repeats on the
Figure 2. Structure of Prp8pCTF* in isola-
tion. (A) Two possible (close and open) con-
figurations of Prp8pCTF*. (Blue) Prp8pRNaseH;
(cyan) Prp8pJab1/MPN; (dashed line) flexible
linker. Two crystallographically related
Jab1/MPN domains are shown with respect
to the same RNaseH domain. Other, primarily
open, configurations in which the distances
between the domains could be bridged by the
linker can be found with other symmetry-
equivalent Jab1/MPN domains. (B) Gel fil-
tration analysis of Prp8pCTF* after treatment
with trypsin. Details and labeling are as in
Figure 1, C–I. After treatment with trypsin,
the separated domains elute as isolated mol-
ecules, indicating that they do not stably
interact in solution (cf. Fig. 1F).
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opposite side of its VHS-like domain (Meinhart and
Cramer 2004).
Aar2p directly competes with Brr2p binding
at the Prp8p C-terminal region by sequestering
the Jab1/MPN domain
A number of studies have shown that Brr2p also interacts
with the C-terminal region of Prp8p (van Nues and Beggs
2001; Liu et al. 2006; Pena et al. 2007), and it was reported
that more Aar2p associates with Prp8p in cells producing
less Brr2p (Boon et al. 2007). We therefore investigated
whether Aar2p and Brr2p bind competitively to Prp8p.
Gel filtration analysis revealed that Brr2p formed a stable
complex with Prp8pCTF (Fig. 4A,B). However, unlike
Aar2p, Brr2p interacted stably with Prp8pJab1/MPN but
not with Prp8pRNaseH (Fig. 4C).
Despite the preferred open structure of isolated
Prp8pCTF, which might permit concomitant binding of
both Aar2p and Brr2p, we could not assemble a ternary
Aar2-His6p–Prp8p
CTF–Brr2p complex. Mixing the three
proteins stoichiometrically produced primarily a binary
Aar2-His6p–Prp8p
CTF complex and free Brr2p (Fig. 4D).
Increasing amounts of Brr2p led to formation of a mixture
of binary Brr2p–Prp8pCTF and Aar2-His6p–Prp8p
CTF com-
plexes but were not able to displace Aar2-His6p quanti-
tatively (Supplemental Fig. S4).
These findings could be explained if a preformed Aar2-
His6p–Prp8p
RNaseH complex sequestered the Jab1/MPN
domain, making it unavailable for Brr2p. This idea is
consistent with the observation that a transposon in-
sertion in the C-terminal Jab1/MPN domain of Prp8p (at
residue 2173) interfered with Aar2p binding to U5 snRNP
(Boon et al. 2006), suggesting an involvement of the
Jab1/MPN domain in Aar2p binding to Prp8p. Indeed,
we observed that addition of Prp8pJab1/MPN to a pre-
formed Aar2p–Prp8pRNaseH complex assembled a ter-
nary complex, as revealed in gel filtration (Fig. 4F) and by
GST pull-down assays (Fig. 5A, lanes 22,23). Unlike full-
length Aar2p, a Aar2pSub–Prp8pRNaseH complex did not
bind Prp8pJab1/MPN (Fig. 4, cf. F and G).
The very C terminus of Aar2p, not contained in our
crystal structures, is well conserved among Aar2p ortho-
logs (Supplemental Fig. S3). To test the importance of this
C-terminal tail for binding of Prp8pJab1/MPN, we generated
Aar2DC-His6p lacking only the last 23 amino acids, but, in
Figure 3. Structure of the Aar2pSub–
Prp8pRNaseH complex. (A) Orthogonal views
on the Aar2pSub–Prp8pRNaseH complex
structure. (Violet) Aar2pSub NTD; (red)
CTD; (dashed line) flexible linker between
the domains; (blue) Prp8pRNaseH. Protein
termini, selected secondary structure ele-
ments, and the Prp8pRNaseH thumb and
finger elements are labeled. Roman nu-
merals indicate the two discontinuous in-
terfaces formed upon complex formation.
(B) Book view onto the interacting surfaces
of Aar2pSub and Prp8pRNaseH. Rotations of
the domains relative to the right view in A
are indicated by symbols. Surfaces are col-
ored according to electrostatic potential.
(Blue) Positive charge; (red) negative charge.
(C) Close-up views on interfaces I (left;
rotated 30° about the horizontal axis as
indicated compared with the right panel of
A) and II (right; same view as in the left
panel of A). Selected interacting residues are
shown as sticks, colored by atom type, and
labeled: carbon (as for the respective protein),
nitrogen (blue), and oxygen (red). Dashed
lines indicate hydrogen bonds or salt bridges.
(D) Water molecules (cyan spheres) blanket-
ing the surfaces bordering the central gap
in the Aar2pSub–Prp8pRNaseH complex. (E)
Side-by-side view of the human GGA1
VHS domain (left) (Shiba et al. 2002; PDB
ID: 1JWG) and the Aar2pSub CTD (right).
The N-terminal two helices (H1 and H2 in GGA1VHS; a6 and a7-p1 in Aar2pSub) are shown in gold and are positioned differently relative to
the remainder of the domains (red). The NTDs of Aar2pSub and Prp8pRNaseH are shown in light and dark gray, respectively. Proteins
and selected secondary structure elements are labeled. (F) Comparison of cargo binding by the GGA1 VHS domain (left) with the interaction
of the thumb region of Prp8pRNaseH with the Aar2pSub CTD (right). Cargo peptide and the thumb, respectively, are bound in an elon-
gated conformation between two helices (H6 and H8 in GGA1VHS; a10 and a13 in Aar2pSub CTD). Ligand peptide and the Prp8pRNaseH
thumb are shown as sticks and colored by atom type as in C. Proteins and selected structural elements are labeled.
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contrast to Aar2pSub, retaining the flexible loop between
NTD and CTD. While Aar2DC-His6p stably bound to
Prp8pRNaseH, the preformed Aar2DC-His6p–Prp8p
RNaseH
complex failed to bind Prp8pJab1/MPN (Fig. 4H). Further-
more, unlike full-length Aar2-His6p, Aar2
DC-His6p
allowed formation of a ternary Aar2DC-His6p–Prp8p
CTF–
Brr2p complex, showing that in the Aar2DC-His6p–
Prp8pCTF complex, the Jab1/MPN domain remains avail-
able for binding to Brr2p (Fig. 4E). These data support
a model in which Aar2p bound to the RNaseH domain
provides a binding platform for the Jab1/MPN domain.
The C-terminal 23 amino acids of Aar2p are required for
stable sequestration of Prp8pJab1/MPN and competition
with Brr2p.
Prp8p residues involved in interface I with Aar2p (Fig.
3C, left) belong to a region (residues 2033–2067) in which
Figure 4. Brr2p–Prp8p interaction and mod-
ulation by Aar2p. (A–E) Gel filtration analy-
sis of Brr2p–Prp8p interactions. Details and
labeling are as in Figure 1, C–I. Brr2p (A) com-
igrates with Prp8pCTF (B) and Prp8pJab1/MPN
(C) but not Prp8pRNaseH (C). (C) No ternary
complex Brr2p–Prp8pRNaseH–Prp8pJab1/MPN is
formed. (D) Primarily free Brr2p and the bi-
nary Aar2-His6p–Prp8p
CTF complex form
uponmixing Brr2p, Aar2-His6p, and Prp8p
CTF;
therefore, the Prp8pJab1/MPN domain may be
unavailable to Brr2p (indicated by question
mark ½?). (E) Since the Aar2DC-His6p still
binds the Prp8p RNaseH domain but does
not sequester the Jab1/MPN domain (see H),
the latter remains available for binding Brr2p,
allowing formation of a ternary complex.
(F–H) Gel filtration analysis of Aar2p–Prp8p
interactions. Details and labeling are as in
Figure 1, C–I. (F) Aar2-His6p sequesters
Prp8pJab1/MPN after formation of an Aar2-
His6p–Prp8p
RNaseH complex. Aar2pSub–
Prp8pRNaseH (G) or Aar2DC-His6p–Prp8p
RNaseH
(H) complexes are not able to sequester the
Prp8pJab1/MPN domain, showing that
Prp8pRNaseH and the C-terminal tail of Aar2p
are required to bind Prp8pJab1/MPN.
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Figure 5. Aar2p is phosphorylated. (A) SDS PAGE analysis of Aar2p–Prp8p interactions by GST pull-down. All experiments were
analyzed on the same gel. Numbers on the left indicate the molecular mass of standard proteins (M) in kilodaltons. (I) Mixture added to
the glutathione sepharose; (B) pulled-down (bead) fraction. Proteins or protein mixtures added to the beads are identified above the gel.
Red double arrows connect pull-downs of wild-type Aar2-His6p compared with Aar2
S253E-His6p. GST-Prp8p
RNaseH brought down
significantly reduced amounts of Aar2S253E-His6p (lane 21) compared with wild-type Aar2-His6p (lane 19). Similarly, significantly less
Prp8pJab1/MPN was brought down by GST-Prp8pRNaseH in the presence of Aar2S253E-His6p (lane 25) compared with wild-type Aar2-His6p
(lane 23). (B) Phosphatase treatment indicates that Aar2p is phosphorylated. AGY8 cells were grown in different concentrations of
galactose to induce Aar2-His10p production to increasing levels. After incubation of extracts with Ni
2+-NTA beads, the precipitated
Aar2-His10p was treated with l phosphatase (+) or not () as recommended by the manufacturer (New England Biolabs), fractionated by
SDS PAGE, blotted, and probed with anti-Aar2 antibody (R5725). (C,D) Aar2p has phosphorylated serine(s) and tyrosine(s) in vivo. Aar2-
His10p produced as in A was analyzed by SDS PAGE, blotted, and probed with anti-phospho-serine (mAb p5747, Sigma) (C) or anti-
phospho-tyrosine (mAb 42H4; New England Biolabs) (D) antibodies. (E,F) The S253E variant of Aar2p does not interact with Prp8p. (E)
Extracts from yeast cells producing Prp8E1-HAp and wild-type, S253A, or S253E variants of Aar2-LexA fusion protein or with only
LexAp () were immunoprecipitated with anti-LexA antibodies. Western blot with anti-HA and anti-Prp8 (a8.6) (Boon et al. 2006)
antibodies shows that Aar2pS253E pulls down neither full-length Prp8p nor Prp8E1-HAp. The blot was reprobed with anti-LexA antibody,
showing efficient pull-down of Aar2-LexAp. (F) Extracts from yeast cells producing Prp8E1-HAp or with Gal4AD-HAp (pACT) control as
well as wild-type, S253A, or S253E variants of the Aar2-LexA fusion protein were immunoprecipitated with anti-HA antibodies,
blotted, and probed with anti-LexA, indicating that Prp8E1-HAp interacts with Aar2-LexAp wild type and with S253A, but not with
S253E. Reprobing with anti-HA antibody verified that Prp8E1-HAp was efficiently immunoprecipitated in the three extracts. (G,H) Gel
filtration analysis of Aar2S253E-His6p–Prp8p interactions. Details and labeling are as in Figure 1, C–I. Aar2
S253E-His6p does not form
a stable complex with Prp8pRNaseH (G), but addition of Prp8pJab1/MPN rescues the ternary complex in gel filtration (H).
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amino acid substitutions led to enhanced interaction
with Brr2p (van Nues and Beggs 2001). In light of the
present Aar2pSub–Prp8pRNaseH structure, the direct com-
petition between Aar2p and Brr2p for Prp8p suggests that
this phenotype may be explained in part by reduced
binding of Aar2p and thus easier access of Brr2p to Prp8p.
Aar2p is phosphorylated in vivo
In search of a mechanism that would allow replacement
of Aar2p by Brr2p to form functional U5 snRNP, we
speculated that post-translational modification of Aar2p
might regulate the Aar2p–Prp8p interaction. To test
whether Aar2p is phosphorylated in vivo, extracts from
AGY8 yeast cells (PGAL1:AAR2-His10) were treated with l
phosphatase, which dephosphorylates phospho-serine
(pSer), phospho-threonine (pThr), and phospho-tyrosine
(pTyr) residues, the most frequently phosphorylated
amino acids in eukaryotes (Zhuo et al. 1993). l Phospha-
tase treatment caused Aar2p to migrate faster than non-
treated Aar2p in an SDS denaturing gel (Fig. 5B), indicative
of the removal of one or more phosphate groups. In addi-
tion, antibodies specific for pSer or pTyr detected Aar2p
by Western blotting, with the signal increasing with the
amount of Aar2p in the extracts (Fig. 5C,D). However, there
was no signal with anti-pThr antibodies.
In order to identify the phosphorylated amino acids in
Aar2-His10p, the protein was purified from AGY8 cell
extracts, digested with proteases, and analyzed by mass
spectrometry (MS). Five phosphorylated residues were
found (S253, T274, Y328, S331, and T345) (Supplemental
Fig. S3), confirming the immunodetection of pSer and
pTyr residues and additionally detecting pThr residues,
possibly due to superior sensitivity of the MS approach.
A multiple sequence alignment of Aar2p orthologs
(Supplemental Fig. S3) showed the overall similarity
in the sequences (23.0% identity and 38.3% similarity
between the budding yeast and human proteins) and the
locations of the five phosphorylated amino acids in the
C-terminal third of Aar2p. Among those, only S253 is
conserved in most organisms, including humans, but not
in Arabidopsis thaliana, Caenorhabditis elegans, or
Xenopus laevis. Thus, phosphorylation of S253 might
be important for a widely conserved function of Aar2p.
The Aar2pS253E phospho-mimetic mutation inhibits
binding of Aar2p to Prp8p
To test possible effects of Aar2p phosphorylation on the
ability of Aar2p to bind Prp8p and compete with Brr2p,
we mutated each of these phosphorylated residues to
glutamate (mimicking phosphorylation) or to alanine
(preventing phosphorylation) in the Aar2-LexA fusion
protein, and tested the effect of these mutations in pull-
down assays. Strikingly, the wild-type Aar2-LexA fusion
protein and all of the mutant variants, except S253E,
brought down endogenous Prp8p and the Prp8E1 fusion
protein, whereas the S253E mutant protein reproducibly
did not coprecipitate either protein (Figs. 5E; Supplemen-
tal Fig. S5A,B). Likewise, Prp8pE1 pulled down the S253A
mutant and wild-type Aar2-LexA fusions but not the
S253E variant (Fig. 5F). Furthermore, the smaller S253D
phospho-mimetic substitution behaved like S253E (data
not shown). These results show that the S253E or S253D
phospho-mimetic substitutions inhibit interaction of
Aar2p with Prp8p.
We also investigated the growth phenotypes of yeast
strains overproducing the interacting proteins. Coproduc-
tion of the Aar2-LexA fusion protein and Prp8pE3 was
slightly detrimental to growth at low temperature, and
the coproduction of Aar2-LexAp and Prp8pE3H was even
more so (Supplemental Fig. S5C). These results suggest
that the C-terminal E3 and E3H fragments of Prp8p,
containing the Jab1/MPN domain, might sequester Brr2p,
preventing it from functioning normally. As the growth
inhibition depended on the coproduction of the Aar2-
LexA fusion (data not shown), the effect of sequestering
Brr2p might be exacerbated by the excess Aar2p compet-
ing with endogenous Brr2p for binding to Prp8p.Mutating
the S253 residue in the Aar2-LexA fusion protein to
alanine or glutamate gave opposite effects, with S253A
slightly exacerbating and S253E slightly suppressing the
growth defect (Supplemental Fig. S5C). Thus, the inabil-
ity of Aar2p with the S253E substitution to interact with
Prp8p in vivo alleviates the growth inhibition caused by
overproduction of the Prp8E3 or Prp8E3H proteins, sup-
porting a model in which Aar2p competes with Brr2p for
binding to Prp8p, unless residue S253 is phosphorylated.
We also tested whether the S253Emutation has a direct
effect on binding of Aar2p to Prp8p in vitro. In GST pull-
down assays, a strongly reduced amount of Aar2S253E-
His6p was brought down by GST-Prp8p
RNaseH compared
with wild-type Aar2-His6p (Fig. 5A, lanes 18–21), and the
fraction of Prp8pJab1/MPN pulled down with GST-
Prp8pRNaseH in the presence of Aar2S253E-His6p was
similarly reduced compared with wild-type Aar2-His6p
(Fig. 5A, lanes 22–25). These data show that binding of
Aar2S253E-His6p to Prp8p is strongly reduced comparedwith
wild-type Aar2-His6p, and that this effect is exerted primar-
ily through a reduced interaction with the Prp8p RNaseH
domain. In analytical gel filtration, Aar2S253E-His6p sepa-
rated from Prp8pRNaseH (Fig. 5G), but in the gentler condi-
tions of this assay, addition of the Prp8pJab1/MPN frag-
ment rescued the ternary complex (Fig. 5H). Similarly, in
the reductionist in vitro system, Brr2p was not able to
quantitatively titrate Prp8pCTF fromAar2S253E-His6p. How-
ever, reproducibly more Prp8pCTF was associated with
Brr2p in the presence of Aar2S253E-His6p compared with
wild-type Aar2-His6p (Supplemental Fig. S5D,E). These
results qualitatively agree with the in vivo pull-down data
but suggest that additional factors may be involved in
regulating the Aar2p–Prp8p interaction in vivo.
The Aar2pS253E phospho-mimetic mutation allows
binding of Brr2p to Prp8p and leads to conformational
changes in Aar2p
In order to investigate the effect of the Aar2p mutants on
the ability of Prp8p to bind to Brr2p in vivo, extracts from
cells producing wild-type or mutant Aar2-LexA fusions
were incubated with anti-Prp8 antibodies. Endogenous
Weber et al.
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Prp8p interacted with wild-type Aar2p as well as with the
S253A mutant, but not with the S253E mutant protein
(Figs. 6A; Supplemental Fig. S5F). Concomitantly, the
amount of Prp8p-associated Brr2p increased in extract
containing the S253E variant of the Aar2-LexA protein
(Fig. 6A,B; Supplemental Fig. S5F). These results are
consistent with the idea that phosphorylation of Aar2p
at S253 (mimicked by Aar2pS253E) reduces Aar2p affinity
for Prp8p, allowing Brr2p to interact with Prp8p.
S253 lies directly C-terminal of helix a9 in the Aar2p
CTD (Fig. 6C). Its side chain hydroxyl engages in a direct
hydrogen bond to the backbone carbonyl of L249. Clearly,
conformational adjustments would be required to accom-
modate a phosphate group on S253 and similar confor-
mational rearrangements are expected upon replacement
of S253 with the larger, negatively charged glutamate or
aspartate. In the present conformation, the larger side
chains would lead to steric clashes and the negatively
charged moieties would face a hydrophobic pocket
formed by F183, L205, and L249. The structural changes
are expected to affect the relative positioning of the first
segment of the VHS-like domain, encompassing helices
a6, a7, and p1, which lie on top of S253 (Fig. 6C). Such
conformational changes may explain how S253 phos-
phorylation can affect binding of Prp8pRNaseH, which
occurs remote from the S253 position (Fig. 6C).
Indeed, when subjected to comparative limited pro-
teolysis as a measure of conformational differences,
Aar2S253E-His6p yielded different digestion patterns com-
pared with wild-type Aar2-His6p with a number of pro-
teases tested. For example, upon treatment with trypsin,
fragments of ;24-kDa, 20-kDA, and 18-kDa as well as
several smaller fragments were observed with both mu-
tant and wild-type proteins, but these fragments appeared
at lower trypsin concentrations with the mutant protein,
which also gave rise to a novel band at ;22 kDa (Supple-
mental Fig. S6A).
Circular dichroism (CD) spectra of Aar2-His6p and
Aar2S253E-His6p reproducibly showed small differences
(Supplemental Fig. S6B), indicating some minor changes
in the secondary structure contents (calculated from CD:
35.3/33.2% helix, 18.3/17.8% b strand for wild-type/
S253E Aar2-His6p; crystal structure of Aar2p
Sub relative
to full-length: 33.5% helix, 15.2% b strand). CD melting
profiles showed that both proteins exhibit cooperative
unfolding with a similar melting temperature (46.1°C–
46.5°C) for the main transition (Supplemental Fig. S6C).
Reproducibly, wild-type Aar2-His6p showed a second
minor transition above 60°C. Qualitatively, these results
are in line with differences in the protease digestion
pattern and suggest that upon phosphorylation at S253,
Aar2p would undergo a limited conformational change,
which most likely affects the VHS-like domain and
possibly the C-terminal tail, and that this structural
change leads to reduced affinity for Prp8p.
Discussion
Assembly of snRNPs depends on chaperones
and recycling factors
Assembly of functional macromolecular complexes is
a challenging task in the crowded cellular environment
and is frequently assisted by trans-acting factors (for
review, see Chari and Fischer 2010). Among such factors,
assembly chaperones associate with subunits or partial
complexes to promote the formation of native-like sub-
assemblies, prevent the formation of unproductive in-
teractions, and/or avoid premature contacts. Frequently,
assembly chaperones impose kinetic or thermodynamic
traps that have to be resolved by the action of additional
Figure 6. Influence of Aar2p and variants on the Brr2p–
Prp8p interaction. (A,B) Prp8p interacts with more
Brr2p when bound by less Aar2p (S253E). (A) Full-length
Prp8p was immunoprecipitated from yeast cell extracts
containing the highly expressed wild-type, S253A, or
S253E variants of Aar2-LexAp, or with LexAp as a con-
trol; blotted; and probed with rat anti-Brr2, rabbit anti-
LexA, and rabbit anti-Prp8 primary antibodies, followed
by goat anti-rat IRDye 680LT and donkey anti-rabbit
IRDye 800CW secondary antibodies. The results were
visualized and quantified using a LI-COR Odyssey
imaging system. (B) Average ratios of precipitated
Brr2p/Prp8p and Aar2p/Prp8p are shown for two exper-
iments. Error bars indicate the maximum and mini-
mum values obtained. A similar analysis was also
performed in triplicate using detection by standard
Western blot (see Supplemental Fig. S5F). (C) Position-
ing of S253 in the Aar2pSub–Prp8pRNaseH complex struc-
ture. (Left) Structural overview. The region surround-
ing Aar2p S253 is boxed. Protein termini, domains, and
selected secondary structure elements are labeled. (Right)
Closeup view of the boxed region. Selected residues are
shown as sticks and colored by atom type as in Figure 3C.
(Dashed line) Hydrogen bond.
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assembly factors. Furthermore, different assembly steps
often take place in different cellular or subcellular com-
partments. These principles are nicely illustrated in the
biogenesis of Sm core RNPs in metazoans (Chari and
Fischer 2010). However, it is presently unknown to what
extent and how the de novo assembly of snRNP-specific
proteins is also regulated.
Continued pre-mRNA splicing requires snRNP recy-
cling and reassembly, since several snRNPs are composi-
tionally and structurally remodeled during the splicing
process (Wahl et al. 2009). As the Sm core RNPs appar-
ently remain intact during the splicing cycle, the main
task in recycling of snRNPs may be the reorganization of
snRNAs and reassociation of snRNP-specific proteins.
While Prp24p and the U6-associated Lsm2–8 protein
complex indeed assist reassembly of U4 and U6 snRNAs
after each round of splicing (Raghunathan and Guthrie
1998; Verdone et al. 2004), no recycling factors for snRNP-
specific proteins have so far been characterized.
Aar2p—an assembly factor for a U5
snRNP-specific protein
Like the U4/U6 di-snRNP, U5 snRNP is also profoundly
remodeled during splicing (Makarov et al. 2002). Based on
the documented precursor–product relationship between
Aar2p-U5 snRNP and mature U5 snRNP in yeast (Boon
et al. 2007), and since Aar2p depletion interferes with
repeated rounds of splicing in vitro (Gottschalk et al.
2001), we investigated Aar2p as a candidate assembly and
recycling factor for U5 snRNP-specific proteins.
We show that Aar2p forms a stable complex with the
C-terminal region of the U5-specific Prp8p, binding its
RNaseH domain and sequestering its Jab1/MPN domain
via Aar2p’s C terminus. It thereby hinders Brr2p from
interacting with the Jab1/MPN domain. Our in vitro
binding analyses demonstrate that Brr2p alone is ineffi-
cient in displacing Aar2p from Prp8p (Supplemental
Fig. S4), suggesting that Aar2p imposes a kinetic or
thermodynamic trap on U5 snRNP assembly, possibly
functioning as an assembly chaperone. Phosphorylation
mimicry at residue S253 of Aar2p reduces the affinity of
the protein for Prp8p, and our data indicate structural
changes in Aar2pS253E compared with wild-type Aar2p.
Similar structural changes can be expected upon phos-
phorylation at position 253. Therefore, a presently un-
identified Ser/Thr protein kinase may act as another U5
snRNP assembly factor that overcomes the block im-
posed by Aar2p. Taken together, our results demonstrate
that Aar2p is a veritable U5 snRNP assembly factor,
which, unlike previously characterized snRNP assembly
factors, is required for the ordered binding of a U5 snRNP-
specific protein, Brr2p (Fig. 7). Further experiments will
be required to determine whether Aar2p actually func-
tions as a molecular chaperone.
Overexpressed Aar2p or Aar2pS253A fusion protein
greatly reduced the amount of Brr2p bound to Prp8p
compared with the control, in which Aar2p is present
only at the endogenous level (minus sign ½ in Fig. 6A,B).
Thus, the excess Aar2 fusion protein inhibits Brr2p
binding to full-length Prp8p. In contrast, overexpressed
Aar2pS253E does not inhibit Brr2p binding to Prp8p and
may even facilitate this interaction, as the amount of
Prp8p-associated Brr2p was reproducibly greater in the
presence of Aar2pS253E than in control extract with no
excess Aar2p (Figs. 6B; Supplemental Fig. S5F). By in-
ference, the S253-phosphorylated variant, may have the
ability to make Brr2p more accessible to Prp8p, possibly
by sequestering an unknown factor that inhibits interac-
tion of Brr2p with Prp8p. For a better understanding of the
protein interactions, this should be further studied, with
the mutant protein expressed at the endogenous level.
Taken together, while our data do not provide ultimate
proof of the mechanism of Aar2p/Brr2p exchange, they
provide strong evidence for the involvement of an Aar2p
kinase.
Although the RNaseH and Jab1/MPN domains of Prp8p
do not stably interact in isolation (Fig. 2B), the close
Figure 7. Model for the U5 snRNP maturation. New
elements added to the U5 snRNP maturation model
proposed by Boon et al. (2007). Aar2p-U5 snRNP is
assembled in the cytoplasm and transported to the
nucleus. In the nucleus, Aar2p is phosphorylated by
an unidentified kinase (Kinase X). Phosphorylated
Aar2p exhibits reduced affinity for Prp8p, leaves the
pre-U5 snRNP, and allows Brr2p entry. In view of our
finding that the RNaseH and Jab1/MPN domains,
which are joined by a flexible linker region, do not
interact, we propose that the C terminus of Prp8p takes
on a different conformation when not bound by Aar2p.
Additional U5 snRNP proteins lacking from Aar2p-U5
snRNP are presumably assembled concomitantly with
Brr2p (Boon et al. 2007). Phosphorylated Aar2p has
a possible active role in recruiting Brr2p (not shown).
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configuration of the Prp8pCTF* fragment (Fig. 2A, left) may
still represent a biologically relevant interaction between
these domains, which is too weak to survive gel filtration
or pull-down assays with the separated domains. The
surface of the RNaseH domain that interacts with Aar2p
is still accessible in the close conformation of Prp8pCTF*.
Furthermore, the C-terminal ; 35 residues of the Prp8p
Jab1/MPN domain, which comprise a putative Brr2-bind-
ing region (Pena et al. 2007), are also surface-exposed in the
close conformation of Prp8pCTF*. However, since in a com-
bined model the Jab1/MPNC terminus is remote from the
Aar2p binding site on the RNaseH domain (data not
shown), additional structural and biochemical studies
are required to clarify whether the close conformation
of Prp8pCTF* is relevant for the sequestering of the Jab1/
MPN domain by Aar2p.
Functional significance of the Aar2p-assisted U5
snRNP assembly
What could be the benefit of the complex Aar2p-mediated
U5 snRNP assembly mechanism? Prp8p is an important
scaffolding protein at the heart of the spliceosome and
interacts with all functional elements of the pre-mRNA,
several snRNAs, and other key protein splicing factors
(for review, see Grainger and Beggs 2005). Structural and
functional analyses of the C-terminal region of Prp8p
have suggested that its RNaseH-like domain provides
a platform for the handover of the pre-mRNA 59-splice
site from U1 snRNA to U6 snRNA and may be involved
in stabilizing the catalytic RNA network (Pena et al.
2008; Ritchie et al. 2008; Yang et al. 2008). Consistent
with a role during spliceosome catalytic activation, the
C-terminal region of Prp8p encompassing its RNaseH and
Jab1/MPN domains directly modulates the activity of
Brr2p (Maeder et al. 2009; Pena et al. 2009; Zhang et al.
2009).
The C-terminal region of Prp8p directly binds the U4/U6
snRNA duplex (Zhang et al. 2009), and the Prp8p
RNaseH-like domain also interacts with other RNAs,
including a putative mimic of the catalytic RNA core of
the spliceosome (Ritchie et al. 2008). Modeling studies
have suggested that the groove between the thumb and
fingers of the RNaseH-like domain serves as an RNA-
binding site (Pena et al. 2008). Thus, Aar2p binding at the
same site, as shown in the present Aar2pSub–Prp8pRNaseH
cocrystal structure, may prevent premature binding of the
U4/U6 duplex or binding of nonspecific RNAs at this
domain during U5 snRNP assembly.
Upon U4/U6–U5 tri-snRNP formation, Brr2p must be
regulated to avoid unwinding U4/U6 di-snRNA prema-
turely. We suggest that Aar2p regulates the incorporation
of Brr2p into U5 snRNP in a manner that silences the
Brr2p enzymatic activity during U4/U6–U5 tri-snRNP
formation. This suggested role of Aar2p is supported by
the observation that the D281N mutant of yeast AAR2
acts as a suppressor of the temperature-sensitive prp38-1
allele (Pandit et al. 2006) that causes slow release of U1
and U4 snRNAs during catalytic activation (Xie et al.
1998). D281 of Aar2p forms a salt bridge with K2066 of
Prp8p in interface I (Fig. 3C, left), an interaction that is
expected to be weakened upon mutation of D281 to an
asparagine.
As in vitro experiments have indicated a role for Aar2p
in recycling snRNPs during extended splicing reactions
(Gottschalk et al. 2001), Aar2p may have a reciprocal
function, displacing Brr2p from Prp8p in a post-splicing
complex, to facilitate the regeneration of functional U5
snRNPs. Thus, cycles of phosphorylation and dephos-
phorylation of Aar2p may regulate U5 snRNP assembly
and recycling, and identifying the relevant kinase and
phosphatase is the next important step in further eluci-
dating the U5 snRNP (re)assembly mechanism.
Materials and methods
Yeast work
Details of yeast strains and plasmids are provided in Supplemen-
tal Tables S2 and S3. For MS analysis, yeast extract was prepared
from AGY8 (PGAL1:AAR2-His10) cells grown in 2% (w/v) galac-
tose, and Aar2-His10p was affinity-purified using Ni
2+-NTA
beads followed by SDS-PAGE and analyzed as described in the
Supplemental Material.
Analysis of recombinant proteins
All proteins for biochemical, biophysical, and structural studies
were from yeast and, except Brr2p, were produced in E. coli and
purified to near homogeneity by chromatographic techniques.
Brr2p was produced in insect cell culture. Structural integrity
was checked by CD spectroscopy and CD melting analyses.
Targets were crystallized by the sitting drop vapor diffusion
method, and diffraction data were collected at beamline 14.2 of
the BESSY storage ring (Berlin, Germany). The structures were
solved by molecular replacement and refined by standard strat-
egies. Details are given in the Supplemental Material.
Database deposition
Structure coordinates and diffraction data were deposited with
the Protein Data Bank (http://www.pdb.org) under accession
codes 3SBG (Prp8CTF*), 3SBS (Aar2pSub), and 3SBT (Aar2pSub–
Prp8RNaseH) and will be released upon publication.
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